NMS · Medical - Devices

CVRX (CVRX) Stock

$4.88 +2.95% NMS: CVRX Healthcare

Valuation

MetricValue
Price$4.88
Market Cap$129.50M
P/E Ratio-2.98
P/B Ratio4.13
P/S Ratio2.85
EPS (TTM)$0.00
52-Week High$11.30
52-Week Low$4.37
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-135.90%
ROA-50.48%
ROCE-127.50%
Gross Margin-89.47%
Operating Margin-89.47%
Net Margin-89.15%
Debt/Equity2.03
Current Ratio7.85

Annual Financials (USD)

Metric20212022202320242025
Revenue$13.0M$22.0M$39.0M$51.0M$57.0M
Operating Profit$-26.0M$-43.0M$-43.0M$-59.0M$-51.0M
Net Profit$-43.0M$-41.0M$-41.0M$-60.0M$-53.0M
EPS$-2.11$-2.02$-1.99$-2.65$-2.04
Op Margin-199.2%-189.3%-109.7%-116.0%-90.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$153.0M$125.0M$115.0M$133.0M$105.0M
Total Liabilities$7.0M$16.0M$39.0M$62.0M$65.0M
Cash$142.0M$106.0M$91.0M$106.0M$76.0M
Borrowings$0$7.0M$31.0M$50.0M$51.0M

Latest News

CVRx (CVRX) Moves 11.6% Higher: Will This Strength Last? Zacks · Jun 29, 2026 CVRx Announces Chief Financial Officer Transition GlobeNewswire · Jun 9, 2026 CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference GlobeNewswire · May 27, 2026 CVRx to Present at the William Blair 46th Annual Growth Stock Conference GlobeNewswire · May 20, 2026 CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy Zacks · May 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-28.0M$-43.0M$-39.0M$-39.0M$-40.0M
Investing Cash Flow$-2.0M$-1.0M$-1.0M$-3.0M$-1.0M
Financing Cash Flow$0$0$1.0M$3.0M$0
Net Cash Flow$83.0M$-36.0M$-16.0M$15.0M$-30.0M
Free Cash Flow$-29.0M$-43.0M$-40.0M$-41.0M$-41.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-23.83%
Quick Ratio8.89
Interest Coverage-8.50
Return 1Y-29.80%
Return 3Y-67.79%
Return 5Y-74.08%

Ownership

Insiders Held9.55%
Institutions Held63.58%
Institutions Float Held70.29%
Institutional HolderSharesReport Date
Johnson & Johnson4,024,8612026-03-31
NEA Management Company, LLC2,026,0832026-03-31
Blackrock Inc.1,026,5592026-03-31
GSK plc1,007,5832026-03-31
Vanguard Capital Management LLC911,3102026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CERS $2.32 +2.20% -34.25 $467.54M 0.00%
MASS $8.30 -1.31% 12.81 $340.53M 0.00%
NNOX $1.06 +3.92% -1.56 $73.78M 0.00%
OMIOwens & Minor, Inc. $2.68 +8.94% 14.39 $207.07M 0.00%
PRQR $1.88 -1.32% -2.29 $197.45M 0.00%

About CVRX

CVRX is led by CEO Kevin Hykes, employs 206 people, headquartered in US, publicly traded since 2021.

CVRX stock trades at $4.88 with a market capitalization of $129.50M. The stock is valued at a price-to-earnings (P/E) ratio of -2.98, price-to-book of 4.13, price-to-sales of 2.85. Over the past 52 weeks the stock has ranged between $4.37 and $11.30, and currently trades 56.8% below its 52-week high.

On profitability, CVRX generates a return on equity (ROE) of -135.90%, return on capital employed of -127.50%, an operating margin of -89.47%, a net profit margin of -89.15%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides